Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (Loss) Income	$ (9,812)	$ (38,068)
Depreciation and amortization	55,744	53,138
Amortization of Inventory Step-up	0	14,370
Noncash lease expense	5,656	5,286
Provision for doubtful accounts	666	(548)
Provision for warranty and returns	3,951	726
Stock compensation	9,158	12,092
Loss on disposal of property and equipment	367	596
Bond premium amortization	5	130
Debt Issuance Costs amortization	1,701	1,643
Change in fair value of contingent earn-out	(700)	0
Sparepartsusage	4,384	2,223
Other Noncash Income (Expense)	(40)	(1,649)
Accounts receivable	82,028	22,489
Inventories	(49,370)	(36,170)
Prepaid expenses and other assets	1,907	2,607
Increase (Decrease) in Other Operating Assets	(6,448)	(14,371)
Accounts payable	(27,525)	19,504
Accrued liabilities	(21,099)	(19,238)
Income taxes, including excess tax benefits and deferred income taxes	(9,328)	(26,102)
Net cash provided by operating activities	41,245	(1,342)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(14,205)	(23,606)
Proceeds from sale of asset	54	900
Intangible assets additions	(2,532)	(2,387)
Purchases of investment securities	0	(1,993)
Proceeds from sale of investment securities	1,500	3,500
Net cash used in investing activities	(15,183)	(1,867,750)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt, net of lender debt issuance costs	0	1,672,698
Repayments of Long-term Debt	7,375	16,000
Payments of Debt Issuance Costs	0	(1,852)
Proceeds from exercise of stock options	171	2,974
Finance Lease, Principal Payments	(208)	(160)
Payment, Tax Withholding, Share-based Payment Arrangement	8,425	8,743
Net cash (used in) provided by financing activities	(15,837)	1,648,917
Effect of Exchange Rate on Cash [Abstract]
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	1,938	(3,224)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	12,163	(223,399)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	220,947	329,428
Supplemental Cash Flow Information [Abstract]
Capital Expenditures Incurred but Not yet Paid	2,223	5,178
NON-CASH INVESTING ACTIVITIES
Payments to Acquire Businesses, Net of Cash Acquired	0	(1,844,164)
SmithsMedical
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (Loss) Income		40,400
Change in fair value of contingent earn-out	$ (700)
NON-CASH INVESTING ACTIVITIES
Fair Value of Assets Acquired		1,594,776
Net Cash Paid (Received) for current and prior acquisitions		(1,844,164)
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		(575,975)
Business Combination, Liabilities Arising from Contingencies, Amount Recognized		(55,158)
Goodwill, Period Increase (Decrease)		1,485,987
Liabilities Assumed		$ (605,466)